272 related articles for article (PubMed ID: 2866140)
1. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine.
Sun JD; Ragsdale SS; Benson JM; Henderson RF
Fundam Appl Toxicol; 1985 Oct; 5(5):913-9. PubMed ID: 2866140
[TBL] [Abstract][Full Text] [Related]
2. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
Mayer RD; Maines MD
Biochem Pharmacol; 1990 May; 39(10):1565-71. PubMed ID: 2337413
[TBL] [Abstract][Full Text] [Related]
3. Induction of rat UDP-glucuronosyltransferase and glutathione S-transferase activities by L-buthionine-S,R-sulfoximine without induction of cytochrome P-450.
Manning BW; Franklin MR
Toxicology; 1990 Dec; 65(1-2):149-59. PubMed ID: 2125759
[TBL] [Abstract][Full Text] [Related]
4. The pulmonary effects of buthionine sulfoximine treatment and glutathione depletion in rats.
Coursin DB; Cihla HP
Am Rev Respir Dis; 1988 Dec; 138(6):1471-9. PubMed ID: 3202501
[TBL] [Abstract][Full Text] [Related]
5. Effect of N-acetyl-cysteine, D-penicillamine and buthionine sulfoximine on glutathione levels and CNS oxygen toxicity in rats.
Lalitha T; Kerem D; Yannai S
Pharmacol Toxicol; 1990 Jan; 66(1):56-61. PubMed ID: 2308909
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
Kramer RA; Greene K; Ahmad S; Vistica DT
Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
[TBL] [Abstract][Full Text] [Related]
7. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
Dethlefsen LA; Lehman CM; Biaglow JE; Peck VM
Radiat Res; 1988 May; 114(2):215-24. PubMed ID: 3375425
[TBL] [Abstract][Full Text] [Related]
8. A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S,R)-sulfoximine.
Watanabe T; Sagisaka H; Arakawa S; Shibaya Y; Watanabe M; Igarashi I; Tanaka K; Totsuka S; Takasaki W; Manabe S
J Toxicol Sci; 2003 Dec; 28(5):455-69. PubMed ID: 14746349
[TBL] [Abstract][Full Text] [Related]
9. Suppression of plasma estradiol and progesterone concentrations by buthionine sulfoximine in female rats.
Kang YJ; Uthus EO
Biochem Pharmacol; 1996 Feb; 51(4):567-70. PubMed ID: 8619904
[TBL] [Abstract][Full Text] [Related]
10. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
Ozols RF; Louie KG; Plowman J; Behrens BC; Fine RL; Dykes D; Hamilton TC
Biochem Pharmacol; 1987 Jan; 36(1):147-53. PubMed ID: 3801051
[TBL] [Abstract][Full Text] [Related]
11. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
Shrieve DC; Harris JW
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936
[TBL] [Abstract][Full Text] [Related]
12. Drug metabolizing enzyme changes after chronic buthionine sulfoximine exposure modify acetaminophen disposition in rats.
Manning BW; Franklin MR; Galinsky RE
Drug Metab Dispos; 1991; 19(2):498-502. PubMed ID: 1676661
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the acute toxicity of methyl chloride in male B6C3F1 mice by glutathione depletion.
Chellman GJ; White RD; Norton RM; Bus JS
Toxicol Appl Pharmacol; 1986 Oct; 86(1):93-104. PubMed ID: 3764938
[TBL] [Abstract][Full Text] [Related]
14. Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine.
Lee FY; Allalunis-Turner MJ; Siemann DW
Br J Cancer; 1987 Jul; 56(1):33-8. PubMed ID: 3620316
[TBL] [Abstract][Full Text] [Related]
15. Long-term buthionine-sulfoximine-mediated toxicity in cultured hepatoma cell lines.
Dierickx PJ
Res Commun Chem Pathol Pharmacol; 1990 Mar; 67(3):423-6. PubMed ID: 2160706
[TBL] [Abstract][Full Text] [Related]
16. Effects of buthionine sulfoximine on the development of ozone-induced pulmonary fibrosis.
Sun JD; Pickrell JA; Harkema JR; McLaughlin SI; Hahn FF; Henderson RF
Exp Mol Pathol; 1988 Oct; 49(2):254-66. PubMed ID: 2901982
[TBL] [Abstract][Full Text] [Related]
17. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
Mitchell JB; Russo A; Biaglow JE; McPherson S
Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
[TBL] [Abstract][Full Text] [Related]
18. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
Standeven AM; Wetterhahn KE
Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
[TBL] [Abstract][Full Text] [Related]
20. Effects of buthionine sulfoximine and diethyl maleate on glutathione turnover in the channel catfish.
Gallagher EP; Hasspieler BM; Di Giulio RT
Biochem Pharmacol; 1992 May; 43(10):2209-15. PubMed ID: 1350905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
